Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of d-leucine cas 328-38-1 in China. Welcome to wholesale bulk high quality d-leucine cas 328-38-1 for sale here from our factory. Good service and reasonable price are available.
D-Leucine is an amino acid derivative that belongs to the category of branched-chain amino acids (BCAAs). Its molecular formula is C6H13NO2, and it has a molecular weight of 131.17. It exists in the form of a white powder or crystalline solid. It is soluble in water and acetic acid, slightly soluble in ethanol, but insoluble in ether. It is an important intermediate in organic synthesis and medicinal chemistry, and is often used in the modification of polypeptide drug molecules, the synthesis of raw drugs, and as an additive in food and feed. However, the human body cannot produce naturally and it must be obtained through dietary intake. Since it is rarely found in common foods, it is often obtained through fermentation processes.
 |
 |
|
Chemical Formula |
C6H13NO2 |
|
Exact Mass |
131.09 |
|
Molecular Weight |
131.18 |
|
m/z |
131.09 (100.0%), 132.10 (6.5%) |
|
Elemental Analysis |
C, 54.94; H, 9.99; N, 10.68; O, 24.39 |
- Epilepsy Treatment: It has shown potential in terminating epileptic seizures. It effectively lowers long-term potential without affecting basal synaptic transmission, indicating its usefulness in epilepsy management.
- Peptide Synthesis and Drug Modification: It is often used as an intermediate in the synthesis of polypeptide drug molecules and the modification of existing drugs. The presence of the D-form amino acid can enhance the stability, solubility, or biological activity of the drug.
- Research Tool: Serves as a valuable research tool in biochemistry and molecular biology studies. It can be used to probe the function of enzymes, receptors, and other biomolecules that specifically interact with D-amino acids.
- Protein Labeling and Imaging: Can be incorporated into proteins using biosynthetic methods, allowing for the labeling and imaging of proteins in living cells and organisms.
- Nutritional Supplement: While it is not essential for humans, it can be used as a nutritional supplement in food products. It may provide additional benefits, such as improved muscle function or recovery, when combined with other amino acids.
- Animal Feed: It can also be used as an additive in animal feed to enhance the nutritional value and performance of livestock and pets.
- Synthesis of Complex Molecules: Serves as an important intermediate in the synthesis of complex organic molecules, such as pharmaceutical compounds, pesticides, and dyes.
- Chiral Building Block: As a chiral building block, which can be used to construct chiral molecules with specific optical properties or biological activities.
applications in pharmaceutical field
- It has been found to increase the pain threshold in animals, indicating its potential as an analgesic agent. It can be used as an auxiliary drug for laser acupuncture analgesia, providing relief from pain caused by various conditions such as surgery, rheumatic arthritis, sprains, and overexertion.
- When combined with D-Phenylalanine, it forms an amino acid compound that has been proven effective in treating pain in horses, especially for post-operative and rheumatic pain. This combination is safe, effective, and non-addictive.
- It serves as a nutritional supplement, providing additional amino acids to patients who require them. This can help patients regain strength and resist disease, especially those with conditions that deplete amino acid stores.
It is present in certain antibiotics, such as polymyxin E, which exhibits potent antibacterial activity against Gram-negative bacteria, particularly Pseudomonas aeruginosa. This makes it a valuable component in the fight against infectious diseases.
As an optically active organic acid, which plays a crucial role in the asymmetric synthesis of chiral compounds. This is particularly important in the pharmaceutical industry, where chiral purity is essential for the biological activity and safety of drugs.
discovery & development
The journey of D-Leucine began in 1819, when Joseph Louis Proust isolated a white powder from cheese, which he initially termed leucine. It was later discovered that this amino acid, leucine, actually exists in two forms: L-Leucine and D-Leucine, differing only in their chirality.
In 1820, researchers extracted leucine from muscle tissue, recognizing its importance in muscle protein synthesis. They identified it as one of the essential amino acids required for maintaining human health and physiological functions. However, the distinction between L-Leucine and it was not yet made.
Over the next centuries, scientists delved deeper into the chirality of amino acids, realizing that L-forms are typically found in nature, while D-forms are less common. Specifically, was found to have unique properties and applications in biochemical research.
In recent years, it has garnered significant attention due to its potential in biomedical research, protein labeling, and peptide synthesis. Its chirality allows for targeted studies of proteins and enzymes involved in chiral recognition and discrimination. Additionally, it has shown promise in terminating epileptic seizures and other neurological disorders.
In conclusion, the discovery and development of D-Leucine have been a testament to the power of scientific inquiry and its ability to unlock the secrets of biochemistry. Its unique properties continue to inspire new research and applications in various fields.
Independent Research: Breakthroughs in Synthesis and Application
D-leucine, as the D-isomer of leucine, exhibits distinct metabolic activities from the L-isomer due to its unique chiral structure in the biological system, gradually becoming a research focus in the scientific community. In recent years, with the optimization of synthesis techniques and the in-depth analysis of the biological activity mechanism, D-leucine has achieved significant breakthroughs in drug development, neurodisease treatment, and biochemical research.
Breakthrough in Synthesis Technology: From Chemical Synthesis to Bio-Catalysis
The research on the synthesis of D-leucine has undergone a transformation from traditional chemical methods to modern bio-catalysis methods. The key lies in addressing issues such as chiral selectivity, yield, and environmental friendliness.
Optimization of Chemical Synthesis Method
Early studies relied on the synthesis of racemic forms and optical resolution. For example, using isobutyl bromide and acetylacetamide as raw materials, catalyzed by sodium ethoxide, an intermediate was formed, which was then oxidized by sodium hypochlorite to build the carbon chain, ultimately obtaining DL-leucine (a racemic mixture). Subsequently, using tartaric acid and other chiral reagents to form enantiomeric salts, the D-isomer was separated through crystallization, but this method was costly and produced an equal amount of L-isomer as a by-product. In recent years, chemists have achieved the directed synthesis of D-leucine by improving catalysts (such as chiral phosphates) or reaction conditions (such as low temperature and solvent-free environment). For instance, a certain study prepared high optical purity D-leucine through a multi-step organic reaction using isopentyl alcohol as the raw material, after amide formation, carboxylation, and stereoselective construction steps. However, the reaction conditions were harsh and difficult to scale up.
The Rise of Biocatalysis Method
Biocatalysis has gradually become the mainstream method for the synthesis of D-leucine due to its mild conditions and high selectivity.
Microbial Fermentation Method: By genetically engineering microorganisms (such as Escherichia coli, yeast), making them express leucine dehydrogenase or racemase, the precursor substances (such as 4-methyl-2-ketoglutaric acid) are directly converted into D-leucine. For example, a research team introduced the leucine dehydrogenase gene into Escherichia coli, through metabolic pathway regulation (such as knocking out competing enzyme genes), achieving a D-leucine yield of 35g/L, with a fermentation cycle shortened to 48 hours, and a chiral purity of ≥99%.
Enzyme Catalysis Method: Using D-amino acid oxidase to selectively oxidize L-leucine, generating hydrogen peroxide and keto acids, while D-leucine is retained. This reaction requires strict control of pH (7.0-8.0) and temperature (30-35℃), avoiding enzyme inactivation. A certain study used immobilized enzyme technology, allowing the enzyme to be reused more than 10 times, with a yield still remaining above 85%, significantly reducing costs.
Breakthrough in Biological Activity: From Basic Research to Clinical Application
The unique chiral structure of D-leucine enables it to exhibit different activities in the body compared to the L-isomer, especially in anti-epileptic, neuroprotective, and tumor suppression fields, among others.
Antiepileptic activity
The antiepileptic activity of D-leucine is its most significant research breakthrough. Studies have shown that D-leucine can effectively terminate epileptic seizures, even at low doses, and its effect in suppressing persistent epileptic seizures is comparable to that of diazepam, but without sedative effects. In vitro experiments have revealed that D-leucine can reduce long-term neuronal potentials, but does not affect basal synaptic transmission, suggesting that it may exert its effects through non-traditional targets (such as ion channels or receptors). This discovery provides a direction for the development of new antiepileptic drugs, and currently, research has combined it with PARP inhibitors to inhibit the progression of spinal cord tumors.
Neuroprotective effect
D-leucine shows protective effects in neurodegenerative disease models. For example, in the Parkinson's disease model, D-leucine can reduce the aggregation of α-synuclein and alleviate dopaminergic neuron damage; in the Alzheimer's disease model, it can reduce the toxicity of β-amyloid protein and improve cognitive function. These effects may be related to its regulation of autophagy and inhibition of oxidative stress.
Tumor suppression potential
Studies have found that D-leucine can inhibit tumor cell proliferation and induce apoptosis. For example, in the non-small cell lung cancer model, targeted drugs with the D-leucine structure have a tumor suppression rate of 68.3%, and the mechanism may be related to interfering with tumor cell amino acid metabolism or activating immune responses. In addition, D-leucine can also enhance the sensitivity of chemotherapy drugs and reduce drug resistance.
Expansion of application scenarios: From laboratory to industrialization
With the maturity of synthesis technology and the clarification of biological activity, the application scenarios of D-leucine are constantly expanding.
Drug development: As a key intermediate, it is used in the synthesis of anti-tumor, anti-epileptic and immunomodulatory drugs. For instance, a certain pharmaceutical company has incorporated it into the anti-epileptic drug pipeline and plans to enter clinical trials in 2026.
Nutritional supplements: In sports nutrition products, the addition concentration of D-leucine has been increased to 1.8%-3.5%, combined with protein powder to promote muscle synthesis, with a market penetration rate exceeding 22%.
Biochemical research: As a tool reagent, it is used to explore amino acid metabolism, protein synthesis mechanisms and enzyme catalytic reactions, helping scientists deeply understand the laws of biochemistry.
Future outlook: Challenges and opportunities coexist
Although the research on D-leucine has made significant progress, it still faces challenges:
Synthetic cost: Although the biocatalytic method is environmentally friendly, the cost of strain modification and fermentation optimization is relatively high and needs to be further reduced.
Bioactivity mechanism: The specific target and signaling pathway of D-leucine have not been fully clarified yet. Further research is needed.
Clinical transformation: It is necessary to conduct large-scale clinical trials to verify its safety and efficacy, and promote the drug's market launch.
In the future, with the cross-fusion of synthetic biology, structural biology and computational chemistry, the synthesis of D-leucine will become more efficient and environmentally friendly, and its bioactivity mechanism will be comprehensively analyzed, providing new impetus for human health and the advancement of life science.
Hot Tags: d-leucine cas 328-38-1, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, L Carnitine Fumarate Powder, Bis 4 hydroxyphenyl Sulfone CAS 80 09 1, D Melibiose, agarose powder, spermidine powder, Pure Erythritol Powder CAS 149 32 6